By Dominic Chopping
Danish pharmaceutical giant Novo Nordisk has started to gradually increase the supply of lower-dose strengths of its blockbuster Wegovy weight-loss drug, having limited supply in the U.S. since May to safeguard supplies.
Write to Dominic Chopping at dominic.chopping@wsj.com
(END) Dow Jones Newswires
01-31-24 0202ET